Finding the right psychiatric medication can feel like guesswork. You try a medication, wait weeks to assess its effect, deal with side effects, and if it doesn't work, start over. For patients with depression, anxiety, ADHD, or other conditions, this trial-and-error process can be exhausting and discouraging.
What Is GeneSight?
GeneSight is a pharmacogenomic test — it analyzes variations in your DNA that influence how your body metabolizes and responds to psychiatric medications. A simple cheek swab is sent to a lab, which produces a personalized report categorizing medications into three groups: those likely to work as expected, those that may need dose adjustment, and those that may have reduced efficacy or increased side effects for you specifically.
What Does the Science Say?
GeneSight has been studied in multiple clinical trials. The most significant was the GUIDED trial, a large randomized controlled study that found patients whose providers used GeneSight results had significantly better symptom improvement compared to those managed without the genetic data. It's particularly well-studied for antidepressants.
Who Should Consider It?
GeneSight is especially useful if you've tried multiple psychiatric medications without finding the right fit, if you've experienced significant side effects that stopped you from continuing treatment, or if you're starting psychiatric care for the first time and want to narrow the field. Insurance coverage varies — ask our office about your specific plan.
It's not a crystal ball. Your provider still uses clinical judgment, your history, and your goals alongside the genetic data. But for many patients, it meaningfully shortens the path to effective treatment.
Need Support?
Our board-certified PMHNPs are accepting new patients in-person and via telehealth from anywhere in Massachusetts.
Become a New Patient